S12/3 Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore  by Halestrap, Andrew P.
diseases associated with the only TNG mutation are primarily
caused by a severe bioenergetic deﬁciency.
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Opening of the mitochondrial permeability transition pore (MPTP)
plays a key role in cell death, especially necrosis, and mediates the
injury tissues such as the heart and brain experience following
ischaemia and reperfusion. However, the molecular identity of the
MPTP remains uncertain. Knockout studies have conﬁrmed a role for
cyclophilin-D (CyP-D), probably mediated by its peptidyl-prolyl cis-
trans isomerase activity that facilitates a conformational change in an
inner membrane protein. However, knockout studies have cast doubt
on the central role of the adenine nucleotide translocase (ANT),
previously implicated as the channel-forming component of theMPTP.
The evidence for and against a role for the ANT inMPTP openingwill be
reviewed and data presented to suggest that it usually plays a
regulatory role rather than provide the transmembrane pore compo-
nent. Our recent data suggest that the protein fulﬁlling the latter role is
the mitochondrial phosphate carrier (PiC) and recent evidence in
support of this proposal will be summarised. Our data are consistent
with a model for the MPTP in which a calcium-triggered conforma-
tional change of the PiC, facilitated byCyP-D, induces pore opening.We
propose that this is enhanced by an association of the PiC with the “c”
conformation of the ANT. Agents that modulate pore opening may act
on either or both the PiC and the ANT.
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When the mitochondrial membrane potential (Δψm) is compro-
mised, the F1FoATP synthase runs in reverse, and mitochondria switch
from ATP producers to consumers. In studies of the isolated enzyme,
the protein IF1 inhibits ATPase activity at an acidic pH. As its impact on
mitochondrial function in intact cells is not established, we have
explored the effect of overexpression or knockdown of IF1 in cell lines
(HeLa, C2C12). Upon inhibition of respiration, IF1 conserves ATP
(measured using luciferase transfected cells or measurements of
[Mg2+]c) at the expense of mitochondrial depolarisation and reduces
hypoxic cell death. Knocking down the protein promoted conservation
of Δψm at the expense of ATP. Surprisingly, IF1 also had a profound
impact on mitochondrial structure and function: IF1 overexpression
increased both the number of mitochondrial cristae and ATP synthase
activity, decreasing Δψm and favouring a dependence of ATP home-
ostasis on oxidative phosphorylation. Knocking down the protein had
the opposite effect. Further, using immunoﬂuorescence, we found that
the relative expression of IF1 to ATPase is considerably greater in
primary neuronal cultures compared to adjacent astrocytes, showing
that IF1 expression level is not ﬁxed in relation to the ATPase. These
observations show that IF1 has an inﬂuence onmitochondrial function
at rest and that it is effective at preserving cellular ATP in hypoxic or
ischaemic conditions.
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Cellular glutamate pathways are essentially controlled by
mitochondrial metabolism. Although enzymes of the mitochondrial
matrix have been studied quite extensively, the regulation of
mitochondrial membrane carriers is still rather mysterious. More-
over, recent advances show that it is inappropriate to extrapolate
regulation models acquired from one cell model to another, as every
tissue uses glutamate for speciﬁc functions. Very little is known
about molecular mechanisms responsible for tissue speciﬁcities. For
instance, expression of different isoforms of glutamate carriers
might contribute to tissue speciﬁcity. Regarding glutamate dehy-
drogenase, ﬂux direction depends on metabolic parameters such as
substrate availability, redox and energy state of mitochondria. These
parameters may be tissue speciﬁc. At the post-translational level,
new modes of regulations have been described these recent years.
Indeed, ADP-ribosylation of GDH mediated by SIRT4 offers another
regulatory mechanism that might be tissue speciﬁc, pending
different levels of SIRT4 expression. This newly identiﬁed mode of
regulation certainly deserves further investigations to better
integrate molecular and cellular glutamate pathways into metabolic
homeostasis at the organism level.
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Pancreatic beta cells secrete insulin when blood glucose levels are
high. Dysfunction of this glucose-stimulated insulin secretion (GSIS) is
partly responsible for themanifestation of type 2 diabetes, ametabolic
disorder that is rapidly becoming a global pandemic. Mitochondria
play a central role in GSIS by coupling glucose oxidation to production
of ATP, a signal that triggers a series of events that ultimately leads to
insulin release. Beta cells express a mitochondrial uncoupling protein,
UCP2, which is rather surprising as activity of such a protein is
anticipated to lower the efﬁciency of oxidative phosphorylation, and
hence to impair GSIS. The mounting evidence demonstrating that
insulin secretion is indeed blunted by UCP2 agrees with this
prediction, and has provoked the idea that UCP2 activity contributes
to beta cell pathogenesis and development of type 2 diabetes.
Although this notion may be correct, the evolved function of UCP2
remains unclear. In this lecture, data will be presented that were
obtained from our RNA interference studies to probe the effect of Ucp2
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